In Diagnostics
In Diagnostics offers next-gen POC devices, including the first disposable spectrophotometer for liver enzyme tests.
Founded
2018In Diagnostics offers next-gen POC devices, including the first disposable spectrophotometer for liver enzyme tests.
In Diagnostics, founded in Carlsbad, California, is dedicated to revolutionizing point-of-care (POC) testing with next-generation devices. Their core mission is to provide accessible, lab-quality diagnostic tools that require minimal sample volumes and no complex preparation. Their flagship product, Quic ALT + AST, is the world's first disposable spectrophotometer designed for liver enzyme testing using just 20 microliters of whole blood. This innovation aims to make high-quality diagnostics available in any setting, enhancing patient care and streamlining medical workflows.
Notable affiliated individuals and investors include key figures in the medical device and biotechnology sectors, although specific names are not disclosed. In Diagnostics has achieved significant milestones, including the development and manufacturing of their pioneering spectrophotometer entirely in the U.S. Their impact is evident in the improved efficiency and accessibility of liver enzyme testing, providing a reliable alternative to traditional laboratory instruments with over 90% correlation.
Companies similar to In Diagnostics include Instadiagnostics, Prompt Diagnostics, Test Diagnostics and IncellDx.
In Diagnostics was founded in 2018.
In Diagnostics' headquarters is located in Carlsbad, CA, US.
In Diagnostics' most recent funding round was for $3M (USD) in September 2019.
As of Sep 5, 2019, In Diagnostics has raised a total of $3M (USD).
In Diagnostics has 2 employees as of Feb 4, 2024.
Test Diagnostics
